ERBB2 and cancer: Entropy on Postcontrast T1 and T2 was higher in cancers with poor prognostic factors such as ER negativity, PR negativity, HER2 positivity, Ki67 positivity, high grade, and nonluminal subtypes including HER2-enriched and triple-negative cancers (Table 3).